Investment Management Firms
CRISIL helps investment managers around the world improve financial and investment performance by optimizing research.
The passage of MiFID II and industry-wide margin declines have forced investment management firms to reassess long-established research consumption practices and budgets. These dramatic changes have led to an in-housing of research among both large and mid-sized buy-side firms, leaving investment managers faced with the challenge of generating actionable alpha while also rationalising MiFID II budgets, ensuring regulatory compliance and plugging research gaps.
CRISIL's end-to-end research and risk advisory support helps investment managers address these complex issues. Our extensive research platform acts as an extension of internal capabilities, allowing buy-side firms to both maximise the time they spend on the core research that drives performance and meet research needs in non-core or niche segments - while optimizing their research spend. We support firms across investment styles, strategies, mandates, instruments, sectors and geographies.
Along with our direct research support, our risk management capabilities in credit monitoring, model monitoring, stress testing, technology risk management, and other key areas help our clients improve operational efficiency while enhancing client management, asset retention and growth.
Our Offerings
CRISIL EDGE
Questions
Looking for high-end research and risk services? Reach out to us at:
United States
1-855-595-2100/
+1 646 292 3520
United Kingdom
+44 (0) 870 333 6336
India
+91 22 33 42 3000 /
+91 22 61 72 3000
Trusted partner for 55+ global buy-side firms, including private equity firms, hedge funds and wealth managers
Deep domain expertise for delivering differentiated research
High-quality global talent pool with varied skill sets
Comprehensive risk monitoring support tailored for investment management needs
Quick ramp-up/ramp-down model with access to large talent pool, especially during live deals
Cost-effective model streamlines MiFID-II research budgets